CN1631247A - Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof - Google Patents
Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof Download PDFInfo
- Publication number
- CN1631247A CN1631247A CNA200510002275XA CN200510002275A CN1631247A CN 1631247 A CN1631247 A CN 1631247A CN A200510002275X A CNA200510002275X A CN A200510002275XA CN 200510002275 A CN200510002275 A CN 200510002275A CN 1631247 A CN1631247 A CN 1631247A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- tablet
- limited
- essence
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 235000013402 health food Nutrition 0.000 title claims abstract description 15
- 206010021143 Hypoxia Diseases 0.000 title claims abstract description 9
- 230000007954 hypoxia Effects 0.000 title claims abstract description 9
- 230000002929 anti-fatigue Effects 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 70
- 229960003080 taurine Drugs 0.000 claims abstract description 35
- 239000000463 material Substances 0.000 claims abstract description 28
- 239000000314 lubricant Substances 0.000 claims abstract description 13
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- -1 flow aid Substances 0.000 claims abstract description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 32
- 239000003826 tablet Substances 0.000 claims description 25
- 241001632410 Eleutherococcus senticosus Species 0.000 claims description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 20
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 20
- 229930003451 Vitamin B1 Natural products 0.000 claims description 20
- 229930003471 Vitamin B2 Natural products 0.000 claims description 20
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 20
- 229960002477 riboflavin Drugs 0.000 claims description 20
- 229960003495 thiamine Drugs 0.000 claims description 20
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 20
- 235000010374 vitamin B1 Nutrition 0.000 claims description 20
- 239000011691 vitamin B1 Substances 0.000 claims description 20
- 235000019164 vitamin B2 Nutrition 0.000 claims description 20
- 239000011716 vitamin B2 Substances 0.000 claims description 20
- 235000019158 vitamin B6 Nutrition 0.000 claims description 20
- 239000011726 vitamin B6 Substances 0.000 claims description 20
- 229940011671 vitamin b6 Drugs 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 18
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 16
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 16
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 16
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 16
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 16
- 239000000741 silica gel Substances 0.000 claims description 16
- 229910002027 silica gel Inorganic materials 0.000 claims description 16
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 15
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 15
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 15
- 239000000945 filler Substances 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 235000009508 confectionery Nutrition 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 235000014101 wine Nutrition 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 11
- 238000000576 coating method Methods 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 10
- 239000007884 disintegrant Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 8
- 108010011485 Aspartame Proteins 0.000 claims description 8
- 239000000605 aspartame Substances 0.000 claims description 8
- 235000010357 aspartame Nutrition 0.000 claims description 8
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 8
- 229960003438 aspartame Drugs 0.000 claims description 8
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 8
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 8
- 239000005720 sucrose Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- 230000006870 function Effects 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229960004793 sucrose Drugs 0.000 claims description 7
- 244000246386 Mentha pulegium Species 0.000 claims description 6
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 6
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 6
- 235000010443 alginic acid Nutrition 0.000 claims description 6
- 229920000615 alginic acid Polymers 0.000 claims description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- 238000006116 polymerization reaction Methods 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 6
- 229940013618 stevioside Drugs 0.000 claims description 6
- 235000019202 steviosides Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 239000004375 Dextrin Substances 0.000 claims description 4
- 239000001856 Ethyl cellulose Substances 0.000 claims description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 101000945318 Homo sapiens Calponin-1 Proteins 0.000 claims description 4
- 101000652736 Homo sapiens Transgelin Proteins 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 102100031013 Transgelin Human genes 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 229940072056 alginate Drugs 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 235000008434 ginseng Nutrition 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- 235000010981 methylcellulose Nutrition 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- JJAHTWIKCUJRDK-UHFFFAOYSA-N succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate Chemical compound C1CC(CN2C(C=CC2=O)=O)CCC1C(=O)ON1C(=O)CCC1=O JJAHTWIKCUJRDK-UHFFFAOYSA-N 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 229920003134 Eudragit® polymer Polymers 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 3
- 239000006189 buccal tablet Substances 0.000 claims description 3
- 239000007910 chewable tablet Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004925 Acrylic resin Substances 0.000 claims description 2
- 229920000178 Acrylic resin Polymers 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- 101100273639 Carassius auratus ccna1 gene Proteins 0.000 claims description 2
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims description 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 239000004378 Glycyrrhizin Substances 0.000 claims description 2
- 102000004895 Lipoproteins Human genes 0.000 claims description 2
- 108090001030 Lipoproteins Proteins 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
- 239000008116 calcium stearate Substances 0.000 claims description 2
- 235000013539 calcium stearate Nutrition 0.000 claims description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 238000005859 coupling reaction Methods 0.000 claims description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 claims description 2
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 claims description 2
- 229940043264 dodecyl sulfate Drugs 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960002737 fructose Drugs 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- 229940014259 gelatin Drugs 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- 229940037627 magnesium lauryl sulfate Drugs 0.000 claims description 2
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000004014 plasticizer Substances 0.000 claims description 2
- 229940099429 polyoxyl 40 stearate Drugs 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 229960001462 sodium cyclamate Drugs 0.000 claims description 2
- 229940045902 sodium stearyl fumarate Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims description 2
- 229910002012 Aerosil® Inorganic materials 0.000 claims 1
- 241000360590 Erythrites Species 0.000 claims 1
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 239000000429 sodium aluminium silicate Substances 0.000 claims 1
- 235000012217 sodium aluminium silicate Nutrition 0.000 claims 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 9
- 239000000284 extract Substances 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000007767 bonding agent Substances 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229920003149 Eudragit® E 100 Polymers 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 235000020985 whole grains Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- IKUQEFGEUOOPGY-UHFFFAOYSA-N Eleutheroside B1 Chemical compound COC1=CC=2C=CC(=O)OC=2C(OC)=C1OC1OC(CO)C(O)C(O)C1O IKUQEFGEUOOPGY-UHFFFAOYSA-N 0.000 description 2
- FFDULTAFAQRACT-OVUSVGQASA-N Eleutheroside D Chemical compound COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(O[C@@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-OVUSVGQASA-N 0.000 description 2
- FFDULTAFAQRACT-MWBGVTEFSA-N Eleutheroside E Natural products COc1cc(cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@@H]3OC[C@H]4[C@H]3CO[C@@H]4c5cc(OC)c(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c(OC)c5 FFDULTAFAQRACT-MWBGVTEFSA-N 0.000 description 2
- FFDULTAFAQRACT-JSGUJALWSA-N Eleutheroside E Chemical compound COC1=CC([C@@H]2[C@@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-JSGUJALWSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004413 cardiac myocyte Anatomy 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- ZKNVDVVWFWMIOY-IVCZRNNFSA-N eleutheroside A Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CC)[C@@H](O)[C@H](O)[C@H]5O)C(C)C ZKNVDVVWFWMIOY-IVCZRNNFSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- YYDFZHAEFGGSIC-UHFFFAOYSA-N Eleutheroside B1 Natural products COc1cc2C(=O)C=COc2c(OC)c1OC3OC(CO)C(O)C(O)C3O YYDFZHAEFGGSIC-UHFFFAOYSA-N 0.000 description 1
- 229920003163 Eudragit® NE 30 D Polymers 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000132519 Galactites Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229930190029 eleutheroside Natural products 0.000 description 1
- 239000008769 eleutheroside Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- ZOLPMMWNCLHKPX-UHFFFAOYSA-N ligustrin Natural products CC1=CCC2C1C3OC(=C)C(=O)C3C(O)CC2=C ZOLPMMWNCLHKPX-UHFFFAOYSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a health food with hypoxia preventing and anti-fatigue function and preparation process, which utilizes acanthopanax root extract, taurine and vitamins as raw material, bulking agent, crumbling agent, flow aid, and lubricating agent as adjuvant, and flavoring agent, bonding agent or dressing material, and right amount of effervescent agent can be charged. The invention also discloses the process for preparing the preparation and the use of the preparation.
Description
Technical field
The present invention relates to a kind of health food and preparation technology thereof of hypoxia preventing and anti-fatigue function.The main active of this health food contains siberian Ginseng P.E, taurine and vitamin.The present invention relates to prepare the method for described health food and the application of this product.
Background technology
Fatigue is a kind of sub-health state that is between disease and the health, usually causes diseases such as insomnia, indigestion, hypertension, very harmful to the mankind.Along with rapid development of economy, dog-eat-dog, rhythm of life is accelerated, and fatigue just influences human beings'health with darker degree and wider scope.That tired crowd often occurs is unable to do what one wishes, lack phenomenons such as life enthusiasm and enjoyment.
The present invention is a main active with wilsonii and taurine, and development removes a kind of functional food of alleviating fatigue, anti-anoxic.
The main chemical compositions of wilsonii has eleutheroside A (Eleutheroside A, be the cupreol glycoside), Eleutheroside B (being ligustrin Syringin), Eleutheroside B 1 (promptly 6,8-escoparone-7-glycoside), eleutheroside (being the galactite glucoside), eleutheroside D and E (being two kinds of not glycosides of the syringaresinol of isomorphism type) etc.In addition, still contain polysaccharide and 1-sesamin (1-Sesamin).
Acanthopanax senticosus is like genseng, have the function of regulating the body disorder and make it to be tending towards normal effect, " adapting to former " sample effect is arranged, can regulate the metabolic function of body, improve the nonspecific resistance of body the destructive stimulus factor (as cold, scorching hot, overweight, overlabor, the irradiation of x line etc.); Can strengthen the function of hypophysis-interrenal system, improve the adaptability and the tolerance of body, lower of the infringement of the multiple virulence factor in inside and outside body.After the senile chronic patient obeys the wilsonii preparation, can strengthen muscle power, make symptom such as weak, tired, poor appetite eliminate or alleviate, and the effect of improving mental activity and raising eyesight, hearing is arranged.Be used for senile debility clinically,, poor appetite weak to body void, insomnia and dreamful sleep, neurosis etc. have certain curative effect.
Pharmacological research shows that siberian Ginseng P.E has following effect:
1. good antifatigue effect is arranged, remarkable than genseng, and can improve hypoxia-bearing capability significantly;
2. can strengthen body nospecific immunity protection capability, mouse reticuloendothelial system phagocytic function is significantly strengthened, normal mouse and mice with tumor spleen weight are increased, macrophage mean value obviously increases in the spleen;
3. formation that can enhancing antibody;
4. improve mouse e rosette formation rate;
5. the leucocyte that rabbit benzene poisoning and mouse are taken caused by cyclophosphamide reduces all prevention effect;
6. the transfer and the spontaneous leukaemia of mouse of transplanting cancer, cancer had certain inhibitory action, its effect is stablized by force than genseng, and can alleviate the toxicity of cancer therapy drug.The extract of Radix Acanthopanacis Senticosi root still has central excitation, the anti-power of regeneration that stress, promote liver, improve the biosynthesis of protein, reduce basic metabolism, promote sexual gland and effect such as bring high blood pressure down.
Experiment shows that the work that wilsonii increases the body nonspecific resistance is the strongest in order to eleutheroside e.This product is taken for a long time and is not seen any bad reaction.
Taurine is a kind of special amino acid, is the requisite a kind of nutrient of human body, and the marvellous effect of balance health is arranged.Except eyes, taurine also has important effect to other organ.For example, through studies confirm that content of taurine is the highest in the human heart.Taurine strengthens cardiac function by protecting cardiac muscle.Measure when too high when calcium ion inflow among the cardiac muscle cell, will cause coronary heart disease.Taurine can be adjusted the amount of calcium ion among the cardiac muscle cell, keeps its balance, realizes cardiac stimulant.The relation of taurine and heart has become one of problem of whole world primary study.In addition, taurine all has protective effect to lung, liver, stomach and intestine etc.
Aspect daily life, the most significant effect of taurine just is to strengthen immunity and antifatigue.Taurine can and generate the avirulence material in conjunction with the hypochlorous acid in the leucocyte, reduces the destruction of hypochlorous acid to leucocyte self, thereby improves body immunity.Simultaneously, taurine can be kept cardiac function, makes blood circulation normalization, thereby eliminates tired product, makes human body produce power effectively.Keep constant taurine in the body, just can eliminate fatigue effectively, this is a key factor of keeping health.
Summary of the invention
The object of the present invention is to provide a kind of prescription and preparation method thereof of health food of hypoxia preventing and anti-fatigue function.The contained main active of the present invention has siberian Ginseng P.E, taurine and vitamin.Vitamin among the present invention comprises the vitamin that all are known, can singlely use, use also capable of being combined; Preferred compositions is used vitamin B1, vitamin B2 and vitamin B6.
Can be used in combination by arbitrary proportion between contained each active component of the present invention; The per unit preparation that consists of of preferred active component contains siberian Ginseng P.E 100mg, taurine 200mg, vitamin B1 0.06mg, vitamin B2 0.06mg and vitamin B6 0.06mg.
Health food of the present invention can be made granule, capsule, also can be pressed into various tablets (comprising tablet forms such as plain edition tablet/dispersing tablet, chewable tablets, buccal tablet, oral disnitegration tablet and effervescent tablet).Except that active component, also have auxiliary materials such as filler, disintegrant, lubricant in the prescription, according to circumstances can also add flavouring, glidant, adhesive, effervescent agent or coating material.
The prescription of health food of the present invention consists of: active component (10-90) %, adhesive (0-5) %, filler (10-80) %, disintegrant (0.1-35) %, flavouring (0-40) %, coating material (0-40) %, effervescent agent (0-30) %, glidant (0-5) %, lubricant (0-3) %.
The selection kind of the various auxiliary materials of health food of the present invention is as follows:
Adhesive includes but are not limited to starch, pregelatinized starch, dextrin, maltodextrin, sucrose, Arabic gum, gelatin, methylcellulose, carboxymethyl cellulose, ethyl cellulose, polyvinyl alcohol, polyethylene glycol, polyvinylpyrrolidone (PVP), alginic acid and alginate, xanthans, hydroxypropyl cellulose and hydroxypropyl methylcellulose (HPMC), can use use also capable of being combined separately.
Filler include but are not limited to sweet mellow wine (granular or powdery), xylitol, sorbierite, maltose, Chi ?alcohol, microcrystalline cellulose, PROSOLV SMCC, polymerization sugar (EMDEX), coupling sugar, glucose, lactose, sucrose, dextrin and starch etc., can use separately, also can applied in any combination.
Disintegrant includes but are not limited to microcrystalline cellulose, PROSOLV SMCC, PVPP (PVPP), sodium carboxymethyl starch (CMS-Na), low substituted hydroxy-propyl methylcellulose (L-HPC), Ac-Di-Sol (CCNa) and soybean polyoses (EMCOSOY) etc., can use use also capable of being combined separately.
Flavouring includes but are not limited to sweet mellow wine, xylitol, Stevioside, lactose, fructose, sucrose, albumen sugar, maltitol, glycyrrhizin, Sodium Cyclamate, gelatin, Aspartame, flavoring banana essence, flavoring pineapple essence, vanillic aldehyde, fragrant citrus essence, flavoring orange essence, peppermint essence, ginseng essence, strawberry essence, citric acid, citric acid etc., can use use also capable of being combined separately.
Coating material includes but are not limited to commercially available dressing pre-mixing agent, alginate, shitosan, carboxymethyl cellulose salt, cellulose acetate phthalate ester, ethyl cellulose, methylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, crylic acid resin (homemade acrylic resin I, II, III, IV, Eudragit series), polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol etc., can use use also capable of being combined separately; Corresponding plasticizer can be added, also pigment and color lake etc. can be added.
Glidant includes but are not limited to superfine silica gel powder, talcum powder, Cab-O-sil erosil, hydration sial acid sodium etc., can use use also capable of being combined separately.
Lubricant includes but are not limited to dolomol, calcium stearate, zinc stearate, single stearic acid glycerine lipoprotein, polyethylene glycol, hydrogenated vegetable oil, sodium stearyl fumarate, polyoxyl 40 stearate, single bay sucrose acid ester, sldium lauryl sulfate, magnesium laurylsulfate, Stepanol MG and talcum powder etc., can use use also capable of being combined separately.
Effervescent agent includes but are not limited to the mixture of malic acid, citric acid or fumaric acid and sodium acid carbonate or sodium carbonate.
Another object of the present invention is applied to the aspects such as hypoxia-bearing capability that mammal and people are alleviated fatigue and improved them with each dosage form of health food of the present invention.
Specific embodiment
The following example is in order to describe the present invention better, rather than restriction the present invention.
Embodiment one normal packet garment piece
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. filler microcrystalline cellulose 200.0g;
Starch 300.0g;
3. disintegrating agent carboxymethyl base Starch Sodium 39.82g;
4. magnesium stearate lubricant 10.0g;
5. coating material film coating pre-mix dose 10.0g.
Make 1000 altogether.
Two. the preparation method
1) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, standby;
2) microcrystalline cellulose and starch are crossed 80 mesh sieves respectively, standby;
3) with step 1) and step 2) material mix by recipe quantity, standby;
4) with the material dry granulation of step 3), cross the whole grain of 26 mesh sieves, standby;
5) sodium carboxymethyl starch and the dolomol of adding recipe quantity, mixing;
6) intermediate content detection, determine that sheet is heavy after, send into the tablet press machine compressing tablet, hardness is controlled at 80～100 newton;
7) with plain coating tablets, promptly.
Embodiment two capsules
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. filler microcrystalline cellulose 91.82g;
2 adhesive hydroxypropyl methylcellulose 4.0g;
4. glidant superfine silica gel powder 4.0g;
Make 1000 capsules altogether.
Two. the preparation method
1) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, standby;
2) microcrystalline cellulose and hydroxypropyl methylcellulose are crossed 80 mesh sieves respectively, standby;
3) with step 1) and step 2) material mix by recipe quantity, standby;
4) material with step 3) places high-speed stirring mixer, is that adhesive is granulated with 75% ethanolic solution, crosses the whole grain of 20 mesh sieves, drying;
5) superfine silica gel powder of adding recipe quantity, mixing;
6) encapsulated, promptly.
Embodiment three granules
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. filler microcrystalline cellulose 200.0g;
Sweet mellow wine 434.82g;
Cane sugar powder 400.0g;
3. disintegrant soybean polyoses 150.0g;
4. glidant superfine silica gel powder 15.0g;
Make 1000 pouches altogether.
Two. the preparation method
1) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, standby;
2) microcrystalline cellulose, sweet mellow wine and cane sugar powder are crossed 80 mesh sieves respectively, standby;
3) with step 1) and step 2) material mix by recipe quantity, standby;
4) material with step 3) is the wetting agent wet granulation with 50% ethanolic solution, crosses 35 mesh sieves on extruder, whole grain, and dry back is standby;
5) superfine silica gel powder of adding recipe quantity, mixing;
6) intermediate content detection, pack, promptly.
Embodiment four chewable tablets
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. filler polymerization sugar 440.0g;
Microcrystalline cellulose 80.0g;
3. adhesive hydroxypropyl methylcellulose 3.82g;
4. glidant superfine silica gel powder 8.0g;
5. flavouring Aspartame 5.0g;
Ginseng essence 5.0g;
6. magnesium stearate lubricant 8.0g.
Make 1000 altogether.
Two. the preparation method
1) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, standby;
2) microcrystalline cellulose, Aspartame, ginseng essence and hydroxypropyl methylcellulose are crossed 80 mesh sieves, standby;
3) with step 1) and step 2) material mix by recipe quantity, standby;
4) be that wetting agent is granulated with the material of step 3) with 50% ethanolic solution, cross the whole grain of 26 mesh sieves, standby;
5) polymerization sugar, superfine silica gel powder and the dolomol of adding recipe quantity, mixing;
6) intermediate content detection, determine that sheet is heavy after, send into the tablet press machine compressing tablet, hardness is controlled at 80～100 newton, promptly.
Embodiment five buccal tablets
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. filler sweet mellow wine (granular) 520.0g;
3. adhesive hydroxypropyl methylcellulose 3.82g;
4. glidant superfine silica gel powder 8.0g;
5. flavouring Aspartame 5.0g;
Peppermint essence 5.0g;
6. magnesium stearate lubricant 8.0g.
Make 1000 altogether.
Two. the preparation method
1) with the dissolve with ethanol solution of hydroxypropyl methylcellulose (3 centipoise), standby with 50%;
2) Aspartame is suspended in the above-mentioned solution, standby;
3) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, put in the fluid bed, with step 2) suspension top spray grain, drying;
4) with the material of step 3) and peppermint essence, sweet mellow wine, superfine silica gel powder and the dolomol of recipe quantity, mixing;
5) intermediate content detection, determine that sheet is heavy after, send into the tablet press machine compressing tablet, hardness is controlled at 80～100 newton, promptly.
Embodiment six oral disnitegration tablets
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. coating material Eudragit E100 36.0g;
Eudragit?NE30D?30.0g；
3. filler sweet mellow wine (granular) 410.82g;
4. disintegrant PVPP 48.0g;
Low-substituted hydroxypropyl cellulose 20.0g;
5. flavouring Aspartame 5.0g;
Peppermint essence 5.0g;
6. glidant superfine silica gel powder 8.0g;
7. magnesium stearate lubricant 8.0g.
Make 1000 altogether.
Two. the preparation method
1) with Eudragit E100 and Eudragit NE30D with an amount of 95% dissolve with ethanol solution, standby;
2) Aspartame is suspended in the above-mentioned solution, standby;
3) taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 are crossed 100 mesh sieves respectively, put in the fluid bed, with step 2) suspension at the bottom of the spray dressing, drying;
4) with the material of step 3) and PVPP, low-substituted hydroxypropyl cellulose, peppermint essence, sweet mellow wine, superfine silica gel powder and the dolomol of recipe quantity, mixing;
5) intermediate content detection, determine that sheet is heavy after, send into the tablet press machine compressing tablet, hardness is controlled at 15～35 newton, promptly.
Embodiment seven dispersing tablets
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. coating material hydroxypropyl methylcellulose (3 centipoise) 60.0g;
3. filler sweet mellow wine (granular) 399.82g;
Microcrystalline cellulose 100.0g;
4. disintegrant PVPP 60.0g;
Low-substituted hydroxypropyl cellulose 40.0g;
5. flavouring Stevioside 20.0g;
6. glidant superfine silica gel powder 10.0g;
7. magnesium stearate lubricant 10.0g.
Make 1000 altogether.
Two. the preparation method
1) hydroxypropyl methylcellulose is dissolved with an amount of pure water solution, standby;
2) Stevioside is suspended in the above-mentioned solution, standby;
3) with low-substituted hydroxypropyl cellulose, taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 100 mesh sieves, mixing is put in the fluid bed, with step 2) suspension at the bottom of the spray dressing, drying;
4) with the material of step 3) and microcrystalline cellulose, PVPP, sweet mellow wine, superfine silica gel powder and the dolomol of recipe quantity, mixing;
5) intermediate content detection, determine that sheet is heavy after, send into the tablet press machine compressing tablet, hardness is controlled at 40～100 newton, promptly.
Embodiment eight effervescent tablets
One. prescription
1. raw material siberian Ginseng P.E 100.0g;
Taurine 200.0g;
Vitamin B1 0.06g;
Vitamin B2 0.06g;
Vitamin B6 0.06g;
2. coating material Eudragit E100 36.0g;
3. filler polymerization sugar 203.82g;
Microcrystalline cellulose 100.0g;
5. flavouring Stevioside 20.0g;
6. effervescent agent citric acid 170.0g;
Sodium acid carbonate 150.0g;
6. glidant superfine silica gel powder 10.0g;
7. magnesium stearate lubricant 10.0g.
Make 1000 altogether.
Two. the preparation method
1) with Eudragit E100 with an amount of 95% dissolve with ethanol solution, standby;
2) Stevioside is suspended in the above-mentioned solution, standby;
3) with sodium acid carbonate, taurine, siberian Ginseng P.E and vitamin B1, B2 and B6 100 mesh sieves, mixing is put in the fluid bed, with step 2) suspension at the bottom of the spray dressing, drying;
4) with the material of step 3) and microcrystalline cellulose, citric acid, polymerization sugar, superfine silica gel powder and the dolomol of recipe quantity, mixing;
5) intermediate content detection is determined the heavy back of sheet compressing tablet, and hardness is controlled at 50～100 newton, promptly.
Claims (9)
1. the health food with effects such as hypoxia preventing and anti-fatigue functions is characterized in that contained main active has siberian Ginseng P.E, taurine and vitamin, but is not limited only to siberian Ginseng P.E, taurine and vitamin.
2. the vitamin addressed of claim 1 is characterized in that the vitamin that comprises that all are known can singlely using use also capable of being combined; Preferred compositions is used vitamin B1, vitamin B2 and vitamin B6.
3. claim 1 and 2 described active components is characterized in that can being used in combination by arbitrary proportion between each active component; The per unit preparation that consists of of preferred active component contains siberian Ginseng P.E 100mg, taurine 200mg, vitamin B1 0.06mg, vitamin B2 0.06mg and vitamin B6 0.06mg.
4. claim 1,2 and 3 described health food preparations except that active component, also have auxiliary materials such as filler, disintegrant, lubricant in it is characterized in that writing out a prescription, and according to circumstances can also add flavouring, glidant, adhesive, effervescent agent or coating material.
5. claim 1,2,3 and 4 described health food preparations, what it is characterized in that writing out a prescription consists of active component (10-90) %, adhesive (0-5) %, filler (10-80) %, disintegrant (0.1-35) %, flavouring (0-40) %, coating material (0-40) %, effervescent agent (0-30) %, glidant (0-5) %, lubricant (0-3) %.
6. the various auxiliary materials addressed of claim 4 and 5 is characterized in that selection kind separately is as follows:
Adhesive includes but are not limited to starch, pregelatinized starch, dextrin, maltodextrin, sucrose, Arabic gum, gelatin, methylcellulose, carboxymethyl cellulose, ethyl cellulose, polyvinyl alcohol, polyethylene glycol, polyvinylpyrrolidone (PVP), alginic acid and alginate, xanthans, hydroxypropyl cellulose and hydroxypropyl methylcellulose (HPMC), can use use also capable of being combined separately.
Filler includes but are not limited to sweet mellow wine (granular or powdery), xylitol, sorbierite, maltose, erythrite, microcrystalline cellulose, PROSOLV
SMCC, polymerization sugar (EMDEX
), coupling sugar, glucose, lactose, sucrose, dextrin and starch etc., can use separately, also can applied in any combination.Disintegrant includes but are not limited to microcrystalline cellulose, PROSOLV
SMCC, PVPP (PVPP), sodium carboxymethyl starch (CMS-Na), low substituted hydroxy-propyl methylcellulose (L-HPC), Ac-Di-Sol (CCNa) and soybean polyoses (EMCOSOY
) etc., can use use also capable of being combined separately.
Flavouring includes but are not limited to sweet mellow wine, xylitol, Stevioside, lactose, fructose, sucrose, albumen sugar, maltitol, glycyrrhizin, Sodium Cyclamate, gelatin, Aspartame, flavoring banana essence, flavoring pineapple essence, vanillic aldehyde, fragrant citrus essence, flavoring orange essence, peppermint essence, ginseng essence, strawberry essence, citric acid, citric acid etc., can use use also capable of being combined separately.
Coating material includes but are not limited to commercially available dressing pre-mixing agent, alginate, shitosan, carboxymethyl cellulose salt, cellulose acetate phthalate ester, ethyl cellulose, methylcellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, crylic acid resin (homemade acrylic resin I, II, III, IV, Eudragit
Series), polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol etc., can use use also capable of being combined separately; Corresponding plasticizer can be added, also pigment and color lake etc. can be added.
Glidant includes but are not limited to superfine silica gel powder, talcum powder, Cab-O-sil
, Aerosil
, hydrated sodium aluminosilicate etc., can use use also capable of being combined separately.
Lubricant includes but are not limited to dolomol, calcium stearate, zinc stearate, single stearic acid glycerine lipoprotein, polyethylene glycol, hydrogenated vegetable oil, sodium stearyl fumarate, polyoxyl 40 stearate, single bay sucrose acid ester, sldium lauryl sulfate, magnesium laurylsulfate, Stepanol MG and talcum powder etc., can use use also capable of being combined separately.
Effervescent agent includes but are not limited to the mixture of malic acid, citric acid or fumaric acid and sodium acid carbonate or sodium carbonate.
7. the preparation of the described health food of claim 1 to 6 is characterized in that being prepared into dosage forms such as tablet, capsule and granule.
8. the tablet form addressed of claim 7 is characterized in that not only comprising the plain edition tablet, also comprises tablet forms such as dispersing tablet, chewable tablets, buccal tablet, oral disnitegration tablet and effervescent tablet.
9. described any one the dosage form of claim 1 to 8 is in the application that is used for the tired of releasing mammal and people and improves aspects such as hypoxia-bearing capability.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510002275XA CN100438778C (en) | 2005-01-20 | 2005-01-20 | Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200510002275XA CN100438778C (en) | 2005-01-20 | 2005-01-20 | Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1631247A true CN1631247A (en) | 2005-06-29 |
| CN100438778C CN100438778C (en) | 2008-12-03 |
Family
ID=34852947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200510002275XA Expired - Fee Related CN100438778C (en) | 2005-01-20 | 2005-01-20 | Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100438778C (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102389116A (en) * | 2011-11-23 | 2012-03-28 | 武汉工程大学 | Effervescent tablet for alleviating physical fatigue and preparation technology thereof |
| CN102552247A (en) * | 2012-03-07 | 2012-07-11 | 常州市第四制药厂有限公司 | Composition of vitamin C and preparation method thereof |
| CN102579686A (en) * | 2011-12-06 | 2012-07-18 | 西安泰科迈医药科技有限公司 | Traditional Chinese medicine lozenge and preparing method thereof |
| CN101336723B (en) * | 2008-07-30 | 2012-07-18 | 广州蓝钥匙海洋生物工程有限公司 | Health food for relieving physical fatigue |
| CN102599405A (en) * | 2012-03-15 | 2012-07-25 | 河南省南街村（集团）有限公司 | Binary composite polypeptide chewable tablet |
| CN102599406A (en) * | 2012-03-15 | 2012-07-25 | 河南省南街村（集团）有限公司 | Production process of binary compound polypeptide chewable tablets |
| CN103039985A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of physical fatigue relief function |
| CN103704711A (en) * | 2013-12-31 | 2014-04-09 | 程刚 | Granules with anti-fatigue and health-care function |
| CN103800562A (en) * | 2012-11-06 | 2014-05-21 | 张立中 | Preparation with functions of breath refreshing, spirit improving and fatigue relieving |
| CN104000181A (en) * | 2013-02-27 | 2014-08-27 | 北京宝德润生医药科技发展有限公司 | Composition for relieving physical fatigue and preparation method thereof |
| CN104738450A (en) * | 2015-03-09 | 2015-07-01 | 沈阳农业大学 | Preparation method of stem-free acanthopanax gracilistylus fruit powder and effervescent tablets of stem-free acanthopanax gracilistylus fruit powder |
| CN107149077A (en) * | 2016-03-02 | 2017-09-12 | 广州宏韵医药科技股份有限公司 | Effervescent tablet and preparation method thereof after one kind is run |
| CN114009769A (en) * | 2021-11-25 | 2022-02-08 | 广州白云山汉方现代药业有限公司 | Compound filling agent applied to deoiled yolk powder compound tablet |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096646A (en) * | 1993-06-21 | 1994-12-28 | 徐兴华 | Enriched nutrient powder (paste) with rich mineral substance and vitamines powder (paste) |
| CN1126469C (en) * | 1999-12-14 | 2003-11-05 | 焦柏忠 | Health manyprickle acanthopanax beverage and its making process |
| CN1483355A (en) * | 2002-09-16 | 2004-03-24 | 岚 高 | Anti-fatigue beverage formula |
-
2005
- 2005-01-20 CN CNB200510002275XA patent/CN100438778C/en not_active Expired - Fee Related
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101336723B (en) * | 2008-07-30 | 2012-07-18 | 广州蓝钥匙海洋生物工程有限公司 | Health food for relieving physical fatigue |
| CN102389116A (en) * | 2011-11-23 | 2012-03-28 | 武汉工程大学 | Effervescent tablet for alleviating physical fatigue and preparation technology thereof |
| CN102579686A (en) * | 2011-12-06 | 2012-07-18 | 西安泰科迈医药科技有限公司 | Traditional Chinese medicine lozenge and preparing method thereof |
| CN102579686B (en) * | 2011-12-06 | 2014-05-28 | 西安泰科迈医药科技有限公司 | Traditional Chinese medicine lozenge and preparing method thereof |
| CN102552247A (en) * | 2012-03-07 | 2012-07-11 | 常州市第四制药厂有限公司 | Composition of vitamin C and preparation method thereof |
| CN102599405A (en) * | 2012-03-15 | 2012-07-25 | 河南省南街村（集团）有限公司 | Binary composite polypeptide chewable tablet |
| CN102599406A (en) * | 2012-03-15 | 2012-07-25 | 河南省南街村（集团）有限公司 | Production process of binary compound polypeptide chewable tablets |
| CN103800562A (en) * | 2012-11-06 | 2014-05-21 | 张立中 | Preparation with functions of breath refreshing, spirit improving and fatigue relieving |
| CN103039985A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of physical fatigue relief function |
| CN104000181A (en) * | 2013-02-27 | 2014-08-27 | 北京宝德润生医药科技发展有限公司 | Composition for relieving physical fatigue and preparation method thereof |
| CN103704711A (en) * | 2013-12-31 | 2014-04-09 | 程刚 | Granules with anti-fatigue and health-care function |
| CN103704711B (en) * | 2013-12-31 | 2014-12-10 | 程刚 | Granules with anti-fatigue and health-care function |
| CN104738450A (en) * | 2015-03-09 | 2015-07-01 | 沈阳农业大学 | Preparation method of stem-free acanthopanax gracilistylus fruit powder and effervescent tablets of stem-free acanthopanax gracilistylus fruit powder |
| CN104738450B (en) * | 2015-03-09 | 2017-12-01 | 沈阳农业大学 | The method that effervescent tablet is prepared with Panax sessiliflorus fruit powder |
| CN107149077A (en) * | 2016-03-02 | 2017-09-12 | 广州宏韵医药科技股份有限公司 | Effervescent tablet and preparation method thereof after one kind is run |
| CN114009769A (en) * | 2021-11-25 | 2022-02-08 | 广州白云山汉方现代药业有限公司 | Compound filling agent applied to deoiled yolk powder compound tablet |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100438778C (en) | 2008-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1111404C (en) | The oxybutynin formulations of controlled release | |
| CN1631247A (en) | Health food with hypoxia preventing and anti-fatigue function and preparation technique thereof | |
| CN1957928A (en) | Controlled release preparation of clinical treating medication, and fabricating method | |
| CN1942176A (en) | Pharmaceutical compositions for glucocorticoid replacement therapy | |
| CN1931143A (en) | Orally taken control released trimetazidine medicine composition | |
| CN1527700A (en) | Compaction process for manufacture of sodium phenytoin dosage form | |
| CN1840171A (en) | Chronic kidney disease nutrient solution and preparation method thereof | |
| CN1868463A (en) | Slow-release prepn. contg. alpha-lipoic acid or its derivatives, and preparing method therefor | |
| CN1499961A (en) | Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and cup-shaped envelope of same | |
| CN101028518A (en) | Medicinal composition containing silver ester medicine and ibobulodine | |
| CN100349610C (en) | Oral adhering piece for treating oral exulceratio, and its prepn. method | |
| CN1765362A (en) | Composition containing amlodipine and angiotensin II receptor inhibitor | |
| CN1602945A (en) | Rhinitis treating soft medicinal capsule and preparation process thereof | |
| CN101062039A (en) | Medical combination for treating nervous system diseases | |
| CN1500487A (en) | Oral compound levocetirizine pseudoephedrine formulation and its preparation | |
| CN1478467A (en) | Rapid disintegrate tablet in oral and its preparation method | |
| CN1923182A (en) | Lacidipine tablets disintegrating in oral cavity and process for producing same | |
| CN1160060C (en) | Compressed compositions comprising clarified xanthan gum | |
| CN1307996C (en) | Composition for treating hyperlipemia | |
| CN1304021C (en) | Medicinal composition and its preparing method | |
| CN1217655C (en) | Fibrauretine slow releasing prepn | |
| CN1634496A (en) | A kind of traditional Chinese medicine composition for treating diabetes and preparation method thereof | |
| CN1287834C (en) | Powder for treating coronary heart disease and angina pectoris and its preparing process | |
| CN1586589A (en) | Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method | |
| CN1692906A (en) | Composite for treating hyperlipidemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 100083 Haidian District, Xueyuan Road, No. 30, A building, room No. 15, room, room 15 Patentee after: COSCI MED-TECH Co.,Ltd. Address before: 100080, Haidian District satellite building, No. 63, Zhichun Road, Beijing, room 1410, Beijing Patentee before: COSCI MED-TECH Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081203 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |